Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

被引:0
作者
Olga Millán
Mercé Brunet
Jaume Martorell
Felipe García
Elena Vidal
Isabel Rojo
Montserrat Plana
Teresa Gallart
Tomas Pumarola
Jose M. Miró
Jose M. Gatell
机构
[1] Universitat de Barcelona,Servei Immunologia, Hospital Clínic, IDIBAPS
[2] Universitat de Barcelona,Servei Toxicologia, Hospital Clínic, IDIBAPS
[3] Universitat de Barcelona,Servei Infeccions, Hospital Clínic, IDIBAPS
[4] Universitate de Barcelona,Servei Microbiologia, Hospital Clínic, IDIBAPS
[5] Hospital Clinic de Barcelona,Servei Immunologia
来源
Clinical Pharmacokinetics | 2005年 / 44卷
关键词
Viral Load; Efavirenz; Mycophenolate Mofetil; Abacavir; Mycophenolic Acid;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:525 / 538
页数:13
相关论文
共 50 条
  • [31] The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
    Grinyo, Josep M.
    Ekberg, Henrik
    Mamelok, Richard D.
    Oppenheimer, Federico
    Sanchez-Plumed, Jaime
    Angel Gentil, Miguel
    Hernandez, Domingo
    Kuypers, Dirk R.
    Brunet, Merce
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2269 - 2276
  • [32] Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors
    Arranz-Caso, J
    Gorgolas, M
    Estrada, V
    Garcia-Diaz, JD
    HIV MEDICINE, 2004, 5 (02) : 128 - 129
  • [33] Low body mass index and efavirenz use are independently associated with self-reported fatigue in HIV-infected patients
    Wang, Keran
    Lin, Haijiang
    Li, Lingling
    Wu, Qionghai
    Shen, Weiwei
    Liu, Xing
    Gao, Meiyang
    Zhou, Sujuan
    Ding, Yingying
    He, Na
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (04): : 513 - 518
  • [34] Reversible Gynecomastia in HIV-Infected Man Treated With Triple Antiretroviral Therapy Containing Efavirenz: A Case Report
    Essafi, Mohammed Amine
    Elazizi, Lamiaa
    Aynaou, Hayat
    Salhi, Houda
    El Ouahabi, Hanan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [35] Neuropsychiatric and Neurocognitive Manifestations in HIV-Infected Children Treated With Efavirenz in South Africa - A Retrospective Case Series
    Hammond, Charles K.
    Eley, Brian
    Ing, Natalia
    Wilmshurst, Jo M.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [36] Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients
    de los Santos, Ignacio
    Gomez-Berrocal, Ana
    Valencia, Eulalia
    Asensi, Victor
    Gijon, Paloma
    Moreno, Victoria
    Vergas, Jorge
    Bernardino, Ignacio
    HIV CLINICAL TRIALS, 2013, 14 (05): : 254 - 259
  • [37] EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ON PLATELET ACTIVATING FACTOR METABOLISM IN NAIVE HIV-INFECTED PATIENTS: II) STUDY OF THE ABACAVIR/LAMIVUDINE/EFAVIRENZ HAART REGIMEN
    Chini, M.
    Tsoupras, A. B.
    Mangafas, N.
    Tsogas, N.
    Papakonstantinou, V. D.
    Fragopoulou, E.
    Antonopoulou, S.
    Gargalianos, P.
    Demopoulos, C. A.
    Lazanasi, M. C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (01) : 247 - 258
  • [38] Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon
    Cournil, Amandine
    Coudray, Mathilde
    Kouanfack, Charles
    Essomba, Claudine Ntsama
    Tonfack, Clement Auguste Djouatsa
    Biwole-Sida, Magloire
    Delaporte, Eric
    Bork, Kirsten
    Laurent, Christian
    ANTIVIRAL THERAPY, 2010, 15 (07) : 1039 - 1043
  • [39] Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients
    Liu Li-feng
    Wang Lu
    Fu Qiang
    Zhu Zhu
    Xie Jing
    Han Yang
    Liu Zheng-yin
    Ye Min
    Li Tai-sheng
    CHINESE MEDICAL JOURNAL, 2012, 125 (11) : 1931 - 1935
  • [40] Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naive, HIV-infected patients (SUPPORT): 96-week results
    Kumar, Princy
    DeJesus, Edwin
    Huhn, Gregory
    Sloan, Louis
    Small, Catherine Butkus
    Edelstein, Howard
    Felizarta, Franco
    Hao, Ritche
    Ross, Lisa
    Stancil, Britt
    Pappa, Keith
    Ha, Belinda
    BMC INFECTIOUS DISEASES, 2013, 13